Monthly fasting cycles may be feasible in T2D - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Monthly fasting cycles may be feasible in T2D

  • By

  • Andrea Surnit

  • October 30, 2026

  • 2 min

Share

Objective:

Evaluate the feasibility of monthly 5-day fasting-mimicking diet (FMD) cycles for people with type 2 diabetes (T2D) in primary care.

Approach:
  • Design: One hundred participants were randomly assigned to monthly FMD cycles plus usual care (n=51) or usual care alone (n=49) for 1 year.
  • Participants: Participants were receiving metformin or no glucose-lowering medication.
  • Evaluation: A mixed-methods assessment examined program completion, reasons for discontinuation, serum ketones, treatment satisfaction, and focus-group feedback from 20 participants.
Key Findings:
  • Among participants assigned to FMD, 61% completed the 1-year program; 31% discontinued because of diet-related issues and 8% for other reasons.
  • Serum ketone levels were higher in the FMD group than in the usual-care group; treatment satisfaction did not differ between groups.
  • Reported adherence facilitators included convenience, short cycles, not feeling hungry, motivation, belief in benefits, perceived health improvements, and social support.
  • Reported barriers included the diet’s taste, quantity, and frequency, as well as environmental temptations and lack of social support.
Interpretation:

The study assessed feasibility, not long-term clinical effectiveness. The authors noted that addressing identified facilitators and barriers might enhance adherence.

Limitations:
  • The sample was relatively small.
  • Participants were limited to those taking metformin or no glucose-lowering medication, limiting applicability to people receiving other therapies.
  • The qualitative findings came from 20 participants, and 39% of the FMD group discontinued the program.
Sources:

Original Source(s)

Related Content